Evidence map›Paper›PMID 41589658›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Inhibition of Calcium-Dependent Lipid Droplets Relocation of ACSL4-PKCβ-ALOX15 Complex Alleviates Ferroptosis and Acute Pancreatitis.

Guoyuan Hou, Jing Luan, Xiaoyong Xu, Jianhua Qin, Shuang Ma, Jiyuan He, Na Sun, Wei Zhang, Minghui Gao

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guoyuan HouThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Jing LuanThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Xiaoyong XuHangzhou HuaAn Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.
Jianhua QinThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Shuang MaThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Jiyuan HeThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Na SunThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.
Wei ZhangDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA.
Minghui GaoThe HIT Center for Life Sciences School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang, China.ORCID https://orcid.org/0000-0003-1725-4771

Funding

Harbin Institute of Technology FundingHeilongjiang Natural Science Foundation (Heilongjiang Chunyan Team) CYCX24020
6 · The paper itself

Abstract

Ferroptosis, an iron-dependent form of programmed cell death driven by toxic lipid peroxide accumulation, plays a critical role in various diseases, making its modulation a promising therapeutic strategy. In this study, we identified several L-type calcium channel blockers as novel inhibitors of ferroptosis. We further elucidated that calcium-dependent activation of PKCβ drives ferroptosis by phosphorylating two key enzymes, ACSL4 and ALOX15, at multiple sites. We generated phosphorylation-specific antibodies targeting these sites and confirmed their specificity in the context of ferroptosis. Furthermore, upon induction of ferroptosis, the ACSL4-PKCβ-ALOX15 complex relocates to lipid droplets, highlighting a critical role of lipid droplets in ferroptosis. Notably, elevated PKCβ levels enhance the efficacy of ferroptosis-inducing cancer therapies, while inhibition of the Ca

Indexed as

Arachidonate 15-LipoxygenaseCalciumCoenzyme A LigasesFerroptosisLipid DropletsPancreatitisProtein Kinase C betaAnimalsHumansLong-Chain-Fatty-Acid-CoA LigaseMiceAcsl4 protein, mouseArachidonate 15-LipoxygenaseCalciumCoenzyme A LigasesLong-Chain-Fatty-Acid-CoA LigaseProtein Kinase C betaACSL4acute pancreatitisALOX15calciumferroptosislipid dropletsPKCβ

Identifiers

PMID41589658
PMCPMC13045411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.